| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | ELTP Elite Pharmaceuticals Inc /nv/ | Plassche Douglas | EVP Operations | Sell | 200,000 | $0.58 | $115,800.00 | -8.0% | - | - | |
| Jul 7, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 11,581 | $46.67 | $540,498.01 | -16.6% | +13.1% | - | |
| Jul 2, 2025 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 60,805 | $0.20 | $12,161.00 | +3.8% | - | - | |
| Jul 2, 2025 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 8,000 | $0.11 | $880.00 | +0.3% | - | - | |
| Jul 2, 2025 | NBIX Neurocrine Biosciences Inc | Onyia Jude54 | Chief Scientific Officer | Sell | 20,362 | $130.13 | $2,649,737.60 | -52.7% | +8.5% | - | |
| Jul 2, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $23.47 | $11,733.95 | -0.6% | +13.0% | - | |
| Jul 1, 2025 | RMTI Rockwell Medical, Inc. | Strobeck Mark72 | President And CEO | Sell | 6,926 | $0.82 | $5,679.32 | -2.0% | +52.8% | - | |
| Jul 1, 2025 | RMTI Rockwell Medical, Inc. | Neri Jesse61 | SVP And CFO | Sell | 886 | $0.82 | $726.52 | -0.7% | +52.8% | - | |
| Jul 1, 2025 | RMTI Rockwell Medical, Inc. | Chole Timothy73 | SVP And CCO | Sell | 2,868 | $0.82 | $2,351.76 | -2.2% | +52.8% | - | |
| Jun 30, 2025 | AKBA Akebia Therapeutics, Inc. | Ostrowski Erik | SVP, CFO, Cbo &Treasurer | Sell | 41,314 | $3.67 | $151,622.38 | -7.6% | -25.5% | - | |
| Jun 30, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,572 | $50.50 | $129,886.00 | -1.6% | +18.6% | - | |
| Jun 30, 2025 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 10,425 | $1.23 | $12,822.75 | -11.0% | +28.7% | - | |
| Jun 30, 2025 | CGC Canopy Growth Corp | Kruh Willy74 | Director | Sell | 10,468 | $1.23 | $12,875.64 | -12.5% | +28.7% | - | |
| Jun 30, 2025 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 15,701 | $1.23 | $19,312.23 | -11.7% | +28.7% | - | |
| Jun 30, 2025 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 168 | $4.80 | $807.20 | - | -5.7% | - | |
| Jun 30, 2025 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 168 | $4.80 | $807.20 | - | -5.7% | - | |
| Jun 30, 2025 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 84 | $4.80 | $403.60 | - | -5.7% | - | |
| Jun 30, 2025 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 935 | $4.83 | $4,513.10 | - | -5.7% | - | |
| Jun 27, 2025 | TKNO Alpha Teknova, Inc. | Demski Martha J | Director | Sell | 8,000 | $5.06 | $40,512.00 | -40.0% | +13.3% | - | |
| Jun 26, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $285.70 | $3,142,718.16 | -4.4% | +54.4% | - | |
| Jun 24, 2025 | UTHR United Therapeutics Corp | Mesa Nilda47 | Director | Sell | 645 | $289.99 | $187,045.23 | -11.7% | +43.0% | - | |
| Jun 24, 2025 | UTHR United Therapeutics Corp | Giltner Richard | Director | Sell | 3,036 | $289.60 | $879,214.06 | -13.5% | +43.0% | - | |
| Jun 23, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 23,107 | $47.25 | $1,091,766.47 | -26.8% | +37.4% | - | |
| Jun 17, 2025 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | 7,229 | $1.15 | $8,327.81 | -1.5% | +155.0% | +189.0% | |
| Jun 17, 2025 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L.63 | President And CEO | Sell | 30,474 | $1.11 | $33,795.67 | -1.9% | +155.0% | +189.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.